Check out our official website: http://us.tomonews.net/
Check out our Android app: http://goo.gl/PtT6VD
Check out our iOS app: http://bit.ly/1gO3z1f
------------------------------------------------------------------------------------------------
Thailand's National Science and Technology Development Agency in a press conference on Monday announced its discovery of the P218 chemical, a new anti-malaria drug that is expected to go through pre-clinical trials before being manufactured.
The Thai researchers discovered the protein target responsible for the growth of the parasite's DNA.
By preventing growth of the protein target, the new anti-malarial P218 chemical aims stop the DNA of malaria parasites from replicating. The compound can also completely kill malaria parasites.
The chemical could replace pyrimethamine, the most commonly used antimalarial medication.
The pre-clinical trial is expected to take a year and a half to complete and the human trials will last three years.
Sumalee Kamchonwongpaisan, chief of the research and development team, expressed confidence in the next step of pre-clinical trials as local laboratory tests show no toxicity. If successful, it would take more than five years before the drug becomes publicly available.
------------------------------------------------------------------------------------------------
Welcome to TomoNews, where we animate the most entertaining news on the internets. Come here for an animated look at viral headlines, US news, celebrity gossip, salacious scandals, dumb criminals and much more! Subscribe now for daily news animations that will knock your socks off.
Check out our Android app: https://play.google.com/store/apps/details?id=com.nextmedia.gan
Check out our iOS app: https://itunes.apple.com/app/tomonews/id633875353
For news that's fun and never boring, visit our channel:
https://www.youtube.com/user/TomoNewsUS
Subscribe to stay updated on all the top stories:
https://www.youtube.com/channel/UCt-WqkTyKK1_70U4bb4k4lQ?sub_confirmation=1
Stay connected with us here:
Facebook http://www.facebook.com/TomoNewsUS
Twitter @tomonewsus http://www.twitter.com/TomoNewsUS
Google+ http://plus.google.com/+TomoNewsUS/
Instagram @tomonewsus http://instagram.com/tomonewsus
Check out our Android app: http://goo.gl/PtT6VD
Check out our iOS app: http://bit.ly/1gO3z1f
------------------------------------------------------------------------------------------------
Thailand's National Science and Technology Development Agency in a press conference on Monday announced its discovery of the P218 chemical, a new anti-malaria drug that is expected to go through pre-clinical trials before being manufactured.
The Thai researchers discovered the protein target responsible for the growth of the parasite's DNA.
By preventing growth of the protein target, the new anti-malarial P218 chemical aims stop the DNA of malaria parasites from replicating. The compound can also completely kill malaria parasites.
The chemical could replace pyrimethamine, the most commonly used antimalarial medication.
The pre-clinical trial is expected to take a year and a half to complete and the human trials will last three years.
Sumalee Kamchonwongpaisan, chief of the research and development team, expressed confidence in the next step of pre-clinical trials as local laboratory tests show no toxicity. If successful, it would take more than five years before the drug becomes publicly available.
------------------------------------------------------------------------------------------------
Welcome to TomoNews, where we animate the most entertaining news on the internets. Come here for an animated look at viral headlines, US news, celebrity gossip, salacious scandals, dumb criminals and much more! Subscribe now for daily news animations that will knock your socks off.
Check out our Android app: https://play.google.com/store/apps/details?id=com.nextmedia.gan
Check out our iOS app: https://itunes.apple.com/app/tomonews/id633875353
For news that's fun and never boring, visit our channel:
https://www.youtube.com/user/TomoNewsUS
Subscribe to stay updated on all the top stories:
https://www.youtube.com/channel/UCt-WqkTyKK1_70U4bb4k4lQ?sub_confirmation=1
Stay connected with us here:
Facebook http://www.facebook.com/TomoNewsUS
Twitter @tomonewsus http://www.twitter.com/TomoNewsUS
Google+ http://plus.google.com/+TomoNewsUS/
Instagram @tomonewsus http://instagram.com/tomonewsus
Category
🗞
News